Skip to content

Artificial Intelligent Diagnosis and Platform Application of Depression

Artificial Intelligent Diagnosis and Platform Application of Depression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081102
Enrollment
Unknown
Registered
2024-02-22
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

major depressive disorder

Interventions

Patients with depression group:None
Normal control group:None

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Patients with depression: meet the DSM-5 diagnostic criteria for depression; HAMD score =20. Healthy subjects: The subjects were recruited as healthy controls, and the subjects did not meet any of the DSM-5 diagnostic criteria for mental disorders, and the HAMD score was =8; 2. Aged between 10 and 40 years old; 3. Han nationality, right-handed; Grade 5 and above education; 4. Informed consent to participate in this study (and sign informed consent).

Exclusion criteria

Exclusion criteria: 1. History of neurological disease or major physical disease (such as thyroid disease, lupus erythematosus, diabetes, lung, liver and kidney damage, infection, major trauma, glaucoma, etc.); 2. Present or past history of schizophrenia, bipolar disorder, mental disorders caused by alcohol and drug dependence; 3. Patients who are being treated with hormone drugs; 4. Pregnancy and lactation; 5. Immediate family members with bipolar disorder or mania; 6. Have received ECT treatment within the last 6 months; 7. Hearing impairment; Color blindness; 8. The researcher considers that there are other circumstances that are not suitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale;MATRICS Consensus Cognitive Battery;Magnetic resonance imaging;Speech feature;Facial expression;

Secondary

MeasureTime frame
Hamilton Anxiety Scale;Patient Health Questionnaire-9;Electroencephalogram;Functional near-infrared spectroscopy;

Countries

China

Contacts

Public ContactGaohua Wang

Renmin Hospital of Wuhan University

wgh6402@163.com+86 136 0716 7402

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026